Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Respons...
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
About this item
Full title
Author / Creator
Swadling, Leo , Halliday, John , Kelly, Christabel , Brown, Anthony , Capone, Stefania , Ansari, M Azim , Bonsall, David , Richardson, Rachel , Hartnell, Felicity , Collier, Jane , Ammendola, Virginia , Del Sorbo, Mariarosaria , Von Delft, Annette , Traboni, Cinzia , Hill, Adrian V S , Colloca, Stefano , Nicosia, Alfredo , Cortese, Riccardo , Klenerman, Paul , Folgori, Antonella and Barnes, Eleanor
Publisher
Switzerland: MDPI
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI
Subjects
More information
Scope and Contents
Contents
An effective therapeutic vaccine for the treatment of chronic hepatitis C virus (HCV) infection, as an adjunct to newly developed directly-acting antivirals (DAA), or for the prevention of reinfection, would significantly reduce the global burden of disease associated with chronic HCV infection. A recombinant chimpanzee adenoviral (ChAd3) vector an...
Alternative Titles
Full title
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
Authors, Artists and Contributors
Author / Creator
Halliday, John
Kelly, Christabel
Brown, Anthony
Capone, Stefania
Ansari, M Azim
Bonsall, David
Richardson, Rachel
Hartnell, Felicity
Collier, Jane
Ammendola, Virginia
Del Sorbo, Mariarosaria
Von Delft, Annette
Traboni, Cinzia
Hill, Adrian V S
Colloca, Stefano
Nicosia, Alfredo
Cortese, Riccardo
Klenerman, Paul
Folgori, Antonella
Barnes, Eleanor
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a6cbd27a8f034c38be36821716282824
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a6cbd27a8f034c38be36821716282824
Other Identifiers
ISSN
2076-393X
E-ISSN
2076-393X
DOI
10.3390/vaccines4030027
